Table 5 Geometric mean titers against D614G and Beta in single, double and non-neutralizers.
From: Population shift in antibody immunity following the emergence of a SARS-CoV-2 variant of concern
| Â | GMT D614G | GMT Beta | N | Percentage |
|---|---|---|---|---|
Nov-20 | ||||
 Beta | NN | 182 | 2 | 1,7 |
 D614G | 101 | NN | 51 | 42.1 |
 Double | 220 | 65 | 60 | 49.6 |
 Non-neutralizer | NN | NN | 8 | 6.6 |
Dec-20 | ||||
 Beta | NN | 63 | 14 | 4.5 |
 D614G | 56 | NN | 40 | 12.9 |
 Double | 141 | 89 | 232 | 75.1 |
 Non-neutralizer | NN | NN | 23 | 7.4 |
Jan-21 | ||||
 Beta | NN | 85 | 63 | 22 |
 D614G | 87 | NN | 44 | 15.8 |
 Double | 139 | 163 | 149 | 53.6 |
 Non-neutralizer | NN | NN | 22 | 7.9 |
Feb-21 | ||||
 Beta | NN | 64 | 27 | 27.3 |
 D614G | 44 | NN | 10 | 10.1 |
 Double | 90 | 124 | 56 | 56.6 |
 Non-neutralizer | NN | NN | 6 | 6.1 |
